TB Alliance Appoints Dr. Carlos Morel to Board of Directors

Published: Jan 14, 2010

NEW YORK--(BUSINESS WIRE)--The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of Dr. Carlos Morel to its Board of Directors. Dr. Morel is the Director of the Center for Technological Development in Health (CDTS) of FIOCRUZ, a scientific institution dedicated to biomedical research and development located in Brazil.

Back to news